Please provide your email address to receive an email when new articles are posted on . Non-vitamin K antagonist oral anticoagulants conferred lower risk for ischemic stroke and major bleeding in ...
Anticoagulants are medications that help stop your blood from thickening or “clotting.” Your body does need to be able to clot to help seal wounds inside and outside your body. But unnecessary clots ...
Use of warfarin appears to not only accelerate progression of aortic stenosis (AS) and increase the likelihood of needing an aortic valve replacement (AVR), but also may raise the risk of dying in ...
“Warfarin,” the generic name for a prescription blood thinner first put on the market in the 1950s, might be familiar from television ads for more recent drugs. These ads claim that newer blood ...
New research presented at ACR Convergence, the American College of Rheumatology's annual meeting, shows that use of warfarin, a vitamin K drug widely prescribed to prevent blood clots, is associated ...
DOACs are a newer class of anticoagulants that are more targeted and work faster than traditional options. They also don’t require frequent monitoring and have fewer dietary restrictions. Direct oral ...
The world’s best-selling anticoagulants are typically prescribed for use once or twice daily, depending on their indication and dosage. Anthos Therapeutics, a Cambridge, MA, startup launched with $250 ...
The effectiveness of rivaroxaban, a direct oral anticoagulant, in resolving acute left ventricular thrombus in patients with ST-segment elevation myocardial infarction (STEMI) was similar to that of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results